Cycling Dual-task in Parkinson's Disease

Parkinson Disease Clinical Trial

Official title:

Effects of a Cycling Dual-task Intervention on Cognition and Functionality in Parkinson's Disease: a Pilot Randomized Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05184608
• Other study ID #: 2020/057
• Status: Completed
• Phase: N/A
• Start date: October 11, 2021
• Est. completion date: January 31, 2022

Study information

• Verified date: May 2022
• Source: University of Vigo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: January 31, 2022
• Est. primary completion date: October 28, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Parkinson disease

• Hoehn and Yahr 1 and 2

Exclusion Criteria:

• Hoehn and Yahr >2

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Other:
• Cycling exercise
20 minutes of cycling (90 rpm).
• Cognitive tasks
20 minutes of cognitive tasks based on the different domains of the UPDRS scale.

Locations

Country	Name	City	State
Spain	University of Vigo	Pontevedra

Sponsors (1)

Lead Sponsor	Collaborator
University of Vigo

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Timed Up and Go	Dynamic balance	Change from Baseline Timed Up and Go at 7 weeks
Primary	Sit to Stand test	Lower limbs strength	Change from Baseline Sit to Stan Test at 7 weeks
Primary	Movement Disorder Society - Unified Parkinson's Disease Rating Scale	Parkinson's Disease rating	Change from Baseline Unified Parkinson's Disease Rating Scale at 7 weeks (0-159, better lower values)
Primary	Parkinson's Disease Questionnaire - 39	Quality of life	Change from Baseline Parkinson's Disease Questionnaire - 39 at 7 weeks (0-100, better lower values)
Secondary	Trail Making Test A & B	Attention, visual screening ability and processing speed	Change from Baseline Trail Making Test A & B at 7 weeks
Secondary	Stroop test	Ability to inhibit cognitive interference	Change from Baseline Stroop Test at 7 weeks